Omni Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$92.2M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$65.8M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$64.2M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$53.7M |
| 5 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
+$41.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$120M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$68M |
| 3 |
AWH
Allied World Assurance Co Hld Lt
AWH
|
+$42.8M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$41.3M |
| 5 |
KATE
Kate Spade & Company
KATE
|
+$29.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.73% |
| 2 | Communication Services | 13.77% |
| 3 | Technology | 11.13% |
| 4 | Energy | 10.63% |
| 5 | Utilities | 8.47% |
Similar funds
Omni Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Omni Partners held 38 positions worth $783M, up 0.3% from $781M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Omni Partners deployed $35.3M of net new capital in Q3 2017, opening 10 new positions and adding to 6 existing holdings. Its largest new stake was Kite Pharma, Inc.: 661,711 shares worth $119M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 17% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Brocade Communications Systems, Inc. NEW, an estimated $19.1M trimmed.
- Omni Partners's largest Q3 2017 buy was Kite Pharma, Inc.: 661,711 shares worth $119M.
- Omni Partners added most to Rice Energy Inc. in Q3 2017, an estimated $65.8M increase.
- Omni Partners's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $19.1M.
- Omni Partners fully exited Reynolds American Inc in Q3 2017, selling an estimated $120M.
- Omni Partners's ten largest holdings make up 81% of its $783M portfolio in Q3 2017.
- Omni Partners opened 10 new positions and closed 14 in Q3 2017.
- Omni Partners's portfolio value rose 0.3% quarter-over-quarter to $783M.
Based on Omni Partners's 13F filing for Q3 2017, filed 13 Nov 2017.